MKI67 and breast carcinoma: In order to evaluate the cut-off value of Ki-67 that predicted survival in the luminal breast cancer group and to investigate its survival impact according to axillary lymph node involvement, we retrospectively selected early breast cancer cases with HR positive tumours.